- Home
- WRAP vs CRVO Comparison
WRAP vs CRVO Comparison
Compare WRAP & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRAP
- CRVO
- Stock Information
- Founded
- WRAP 2016
- CRVO 2001
- Country
- WRAP United States
- CRVO United States
- Employees
- WRAP N/A
- CRVO N/A
- Industry
- WRAP Ordnance And Accessories
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- WRAP Industrials
- CRVO Health Care
- Exchange
- WRAP Nasdaq
- CRVO Nasdaq
- Market Cap
- WRAP 73.3M
- CRVO 67.4M
- IPO Year
- WRAP N/A
- CRVO N/A
- Fundamental
- Price
- WRAP $1.34
- CRVO $8.42
- Analyst Decision
- WRAP
- CRVO Strong Buy
- Analyst Count
- WRAP 0
- CRVO 6
- Target Price
- WRAP N/A
- CRVO $17.40
- AVG Volume (30 Days)
- WRAP 164.7K
- CRVO 780.7K
- Earning Date
- WRAP 05-15-2025
- CRVO 08-12-2025
- Dividend Yield
- WRAP N/A
- CRVO N/A
- EPS Growth
- WRAP N/A
- CRVO N/A
- EPS
- WRAP N/A
- CRVO N/A
- Revenue
- WRAP $3,796,000.00
- CRVO $9,308,215.00
- Revenue This Year
- WRAP N/A
- CRVO N/A
- Revenue Next Year
- WRAP N/A
- CRVO N/A
- P/E Ratio
- WRAP N/A
- CRVO N/A
- Revenue Growth
- WRAP N/A
- CRVO 15.14
- 52 Week Low
- WRAP $1.30
- CRVO $1.80
- 52 Week High
- WRAP $2.58
- CRVO $20.63
- Technical
- Relative Strength Index (RSI)
- WRAP 38.74
- CRVO 59.75
- Support Level
- WRAP $1.30
- CRVO $7.81
- Resistance Level
- WRAP $1.50
- CRVO $13.13
- Average True Range (ATR)
- WRAP 0.08
- CRVO 1.06
- MACD
- WRAP -0.00
- CRVO 0.19
- Stochastic Oscillator
- WRAP 16.00
- CRVO 28.64
About WRAP Wrap Technologies Inc.
Wrap Technologies Inc is a public safety technology and services company that delivers safe and effective policing solutions to law enforcement and security personnel worldwide. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.